IASIS HEALTHCARE LLC: 10-Q filed 2013-02-14

Name: IASIS HEALTHCARE LLC: 10-Q filed 2013-02-14
Creator: IASIS HEALTHCARE LLC

What IASIS HEALTHCARE LLC reported in its quarterly report filed 2013-02-14 (fiscal Q1 2013): 29 published measures, 62 facts as tagged in accession 0001193125-13-060295.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-14
Fiscal period: fiscal Q1 2013
Accession: 0001193125-13-060295 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IASIS HEALTHCARE LLC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2012-12-31	2,645,934,000	USD
At 2012-09-30	2,681,616,000	USD
At 2011-12-31	2,649,040,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	2,393,623,000	USD
At 2012-09-30	2,431,080,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-12-31	10,013,000	USD
At 2012-09-30	48,882,000	USD
At 2011-12-31	83,996,000	USD
At 2011-09-30	147,327,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,469,000	USD	92
2011-10-01 to 2011-12-31	1,353,000	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	601,000	USD	92
2011-10-01 to 2011-12-31	-32,701,000	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	30,974,000	USD	92
2011-10-01 to 2011-12-31	24,357,000	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-6,107,000	USD	92
2011-10-01 to 2011-12-31	-8,046,000	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-33,363,000	USD	92
2011-10-01 to 2011-12-31	-22,584,000	USD	92

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,735,000	USD	92
2011-10-01 to 2011-12-31	3,605,000	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	1,176,479,000	USD
At 2012-09-30	1,171,657,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,137,000	USD	92
2011-10-01 to 2011-12-31	500,000	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	6,300,000	USD	92
2011-10-01 to 2011-12-31	6,998,000	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	553,983,000	USD
At 2012-09-30	593,876,000	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	33,845,000	USD	92
2011-10-01 to 2011-12-31	34,940,000	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	320,096,000	USD
At 2012-09-30	352,902,000	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	112,193,000	USD
At 2012-09-30	101,706,000	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit
At 2012-12-31	818,475,000	USD
At 2012-09-30	818,424,000	USD
At 2011-12-31	807,009,000	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-12-31	28,341,000	USD
At 2012-09-30	29,161,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	364,793,000	USD
At 2012-09-30	339,749,000	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	63,722,000	USD
At 2012-09-30	67,650,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-12-31	68,656,000	USD
At 2012-09-30	68,498,000	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-12-31	97,196,000	USD
At 2012-09-30	104,110,000	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	6,388,000	USD	92
2011-10-01 to 2011-12-31	7,238,000	USD	92

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	4,068,000	USD	92
2011-10-01 to 2011-12-31	3,585,000	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	9,700,000	USD	92
2011-10-01 to 2011-12-31	12,300,000	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	26,852,000	USD	92
2011-10-01 to 2011-12-31	28,534,000	USD	92

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,964,000	USD	92
2011-10-01 to 2011-12-31	3,067,000	USD	92

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,000	USD	92
2011-10-01 to 2011-12-31	13,000	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	25,043,000	USD	92
2011-10-01 to 2011-12-31	26,860,000	USD	92

Inspect the source

Entity: IASIS HEALTHCARE LLC / CIK 0001294632
Captured: 2026-09-23 02:48 UTC
SEC response SHA-256: d710cac928fcef21f4fe28df29e0bb403809d1c7e8a3308d2dedd62aa530fe32

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001294632.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))